Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

45
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
45
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

50
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
50
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

48
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
48
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

64
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
64
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

41
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
41
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

34
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
34

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An Agentic LLM Framework for Autonomous Surgical Continuum Monitoring: ReAct-Driven Tool-Use Agents for Presurgical, Intraoperative, and Postsurgical Cardiopulmonary Care.

Bioengineering (Basel, Switzerland)·2026
Same author

Vasa Vasorum-A Silent Enemy After EVAR: A Case Report and Review of the Literature.

Clinics and practice·2026
Same author

Inequalities in Access to and Outcomes of Cardiac Surgery Among Patients with Mental Health Disorders.

Medical sciences (Basel, Switzerland)·2026
Same author

Comprehensive Management of Delayed Pediatric Nail Puncture Injury Complicated by Severe Soft-Tissue Infection: The Adjunctive Role of Negative Pressure Wound Therapy

Chirurgia (Bucharest, Romania : 1990)·2026
Same author

The waiting game: autoamputation of ischemic lower limbs in non-operative management.

Archives of medical sciences. Atherosclerotic diseases·2026
Same author

Life-saving but limb-threatening: vasopressor-induced acral ischaemia and necrosis - two cases and review of the literature.

Archives of medical sciences. Atherosclerotic diseases·2026

Related Experiment Video

Updated: Sep 17, 2025

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

1.8K

VALVE-IN-VALVE IMPLANTATION GONE SOUTH: A CASE REPORT.

Robert Bernat1,2, Volker Windmüller1, Vasileios Leivaditis1

  • 1Westpfalz-Klinikum Kaiserslautern, Germany.

Acta Clinica Croatica
|July 2, 2025
PubMed
Summary

Valve-in-Valve (ViV) procedures are common for failed surgical valves. This case highlights a successful two-transcatheter aortic valve implantation (TAVI) strategy for suboptimal initial ViV placement.

Keywords:
complicationsstructural interventionstranscatheter aortic valve replacement

More Related Videos

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
14:14

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement

Published on: December 11, 2017

14.2K
Four-Dimensional Computed Tomography-Guided Valve Sizing for Transcatheter Pulmonary Valve Replacement
09:57

Four-Dimensional Computed Tomography-Guided Valve Sizing for Transcatheter Pulmonary Valve Replacement

Published on: January 20, 2022

2.8K

Related Experiment Videos

Last Updated: Sep 17, 2025

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

1.8K
Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
14:14

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement

Published on: December 11, 2017

14.2K
Four-Dimensional Computed Tomography-Guided Valve Sizing for Transcatheter Pulmonary Valve Replacement
09:57

Four-Dimensional Computed Tomography-Guided Valve Sizing for Transcatheter Pulmonary Valve Replacement

Published on: January 20, 2022

2.8K

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Transcatheter aortic valve implantation (TAVI) is a growing alternative for aortic valve replacement.
  • Valve-in-Valve (ViV) TAVI is increasingly utilized for failing surgical bioprostheses.
  • Optimal device deployment is crucial for successful TAVI outcomes.

Observation:

  • A 73-year-old male with comorbidities underwent primary TAVI with a 29 mm Evolut valve.
  • Initial TAVI implantation failed due to inability to achieve optimal valve height and hemodynamics.
  • The first TAVI device was repositioned using a snare technique.

Findings:

  • A second TAVI device (29 mm Sapien S3) was successfully implanted after repositioning the initial valve.
  • The dual TAVI procedure resulted in an optimal final hemodynamic result.
  • The patient experienced significant clinical improvement post-procedure.

Implications:

  • This case demonstrates a feasible strategy for managing challenging ViV TAVI cases with suboptimal initial deployment.
  • Repositioning and sequential TAVI implantation can salvage failed ViV procedures.
  • Successful management of complex TAVI cases improves patient outcomes and expands procedural indications.